Account Executive, Journey Clinical
Expanding access to Psychedelic-Assisted Psychotherapy
Open for applications
Expanding access to Psychedelic-Assisted Psychotherapy
21-100 employees
Open for applications
21-100 employees
Company mission
To empower licensed mental health professionals to incorporate Ketamine-Assisted Psychotherapy (KAP) in their practice safely and effectively.
Role
Who you are
- You have 3+ years of experience in consultative sales or consumer sales, (bonus points if you’ve done this in a startup environment, or sold to small businesses before)
- You easily connect and build relationships with people on calls and over emailYou have a deep work ethic, the desire to continuously improve to exceed your objectives with a proven track record of consistently hitting or exceeding quota
- You’re a hungry self-starter who is comfortable thinking on your feet and trying new approaches if you don’t succeed the first time
- You are excited by the opportunity to be a founding member of the sales team, eager to learn from your teammates and are interested in expanding your role over time
- You’re analytical and take a scientific approach to growth, continuously employing A/B testing with a broad range of tactics to understand how to convert new members
- You are passionate about transforming mental health care and believe in our mission to expand access to psychedelic-assisted psychotherapy!
What the job involves
- Own the full sales cycle to drive new member growth in our therapist network (including outbound prospecting, working inbound leads, deal management and closing)
- Play an active role in defining the sales motion and actively co-own the building of our sales function
- Become a Journey Clinical product expert and expand upon or build an understanding of psychedelic assisted psychotherapy to educate prospects on this transformative modality
- Channel your inner “hunter” to penetrate networks of therapists by using targeted emails, calls, texts and referrals
- Work cross functionally in order to translate insights from your sales conversations into products and processes that help the team scale our member network faster
- Work with the co-founders and report directly to the CEO
- This role offers rapid opportunities for advancement within the first 6 months
Otta's take
Sam Franklin
CEO of Otta
With mental health awareness on the rise, the demand for new methods of treatment has increased dramatically. Journey Clinical is meeting this demand by improving access to Psychedelic-Assisted Psychotherapy.
Journey Clinical's main focus is Ketamine Assisted Psychotherapy, which has become increasingly sought after in recent years. KAP has a number of applications, including treatment for anxiety, depression, and PTSD.
Journey Clinical's main challenge will be competing with similar providers, such as Field Trip and Compass Pathways, though its laser focus on KAP should help it stand out. The company has also raised significant funding that will support in scaling its offerings across the US.
Insights
Few candidates hear
back within 2 weeks
70% employee growth in 12 months
Company
Funding (2 rounds)
Jan 2023
$8.5m
SERIES A
Sep 2021
$3m
SEED
Total funding: $11.5m
Company benefits
- Equity options
- Health benefits
- Flexible working hours
- Flexible paid time off
- Growth opportunities and a high level of freedom
- Ketamine-assisted psychotherapy (KAP) prescriber training and mentorship given by leading industry experts
Company HQ
Civic Center, New York, NY
Founders
Jonathan Sabbagh
(CEO)Was Head of Geneva Office at Columbia Threadneedle Investments. Was Managing Director and Founder of Gottex Brokers SA.
Myriam Barthes
(COO)Previously worked as a Manager at EY, and was an AI Impact Strategist and Client Partner at SparkBeyond.
Share this job
View 3 more jobs at Journey Clinical